Literature DB >> 27051013

Association between the MTHFR C677T gene polymorphism and essential hypertension in South West Cameroon.

S M Ghogomu1, N E Ngolle1, R N Mouliom2, B F Asa1.   

Abstract

The association of the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and essential hypertension has been reported but with controversial results in diverse populations in Asia and Europe, thereby suggesting a dependency on ethnicity. The aim of this study was to investigate the association between the MTHFR C677T polymorphism and essential hypertension in a Cameroonian population (Bantu ethnic group) of the South West Region. Analysis of anthropometric and biochemical data in hypertensive and normotensive subjects revealed that age, systolic blood pressure, diastolic blood pressure, low-density lipoprotein cholesterol, serum total cholesterol, and triglycerides are independent risk factors for essential hypertension. Substitution of thymine for cytosine at position 667 of the MTHFR gene was determined by polymerase chain reaction-restriction fragment length polymorphism. Genotype frequencies were found to be 7.3% CC, 58.5% CT, and 34.1% TT for hypertensive subjects compared to 90.0% CC, 10.0% CT, and 0.0% TT for normotensives. Allele frequencies were obtained as 36.6% C and 63.4% T for hypertensive subjects and 95.0% C and 5.0% T for normotensive subjects. These results reveal that the T allele predisposes individuals to hypertension. Therefore, there is an association between variants of the MTHFR gene and hypertension in Cameroonian patients from the South West region.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27051013     DOI: 10.4238/gmr.15017462

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  7 in total

1.  A duplex polymerase chain reaction-restriction fragment length polymorphism for rapid screening of methylenetetrahydrofolate reductase gene variants: Genotyping in acute leukemia.

Authors:  Rim Frikha; Nouha Bouayed; Bochra Ben Rhouma; Leila Keskes; Tarek Rebai
Journal:  J Clin Lab Anal       Date:  2017-04-04       Impact factor: 2.352

Review 2.  Methylenetetrahydrofolate Reductase Polymorphism (rs1801133) and the Risk of Hypertension among African Populations: A Narrative Synthesis of Literature.

Authors:  Sihle E Mabhida; Babu Muhamed; Jyoti R Sharma; Teke Apalata; Sibusiso Nomatshila; Lawrence Mabasa; Mongi Benjeddou; Charity Masilela; Khanyisani Ziqubu; Samukelisiwe Shabalala; Rabia Johnson
Journal:  Genes (Basel)       Date:  2022-04-01       Impact factor: 4.141

3.  Genetic factors contributing to hypertension in African-based populations: A systematic review and meta-analysis.

Authors:  Yandiswa Y Yako; Eric V Balti; Tandi E Matsha; Anastase Dzudie; Deirdre Kruger; Eugene Sobngwi; Charles Agyemang; Andre P Kengne
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-09       Impact factor: 3.738

4.  Effect of interaction between occupational stress and polymorphisms of MTHFR gene and SELE gene on hypertension.

Authors:  Fen Yang; Ruiying Qiu; Saimaitikari Abudoubari; Ning Tao; Hengqing An
Journal:  PeerJ       Date:  2022-02-16       Impact factor: 2.984

Review 5.  Association Between MTHFR Polymorphisms and the Risk of Essential Hypertension: An Updated Meta-analysis.

Authors:  Hao Meng; Shaoyan Huang; Yali Yang; Xiaofeng He; Liping Fei; Yuping Xing
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

6.  The association of MTHFR (rs1801133) with hypertension in an indigenous south African population.

Authors:  Sihle E Mabhida; Jyoti R Sharma; Teke Apalata; Charity Masilela; Sibusiso Nomatshila; Lawrence Mabasa; Hannah Fokkens; Mongi Benjeddou; Babu Muhamed; Samukelisiwe Shabalala; Rabia Johnson
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

7.  Methylenetetrahydrofolate Reductase C677T Gene Polymorphism as a Risk Factor for Hypertension in a Rural Population.

Authors:  Rony Mario Candrasatria; Suko Adiarto; Renan Sukmawan
Journal:  Int J Hypertens       Date:  2020-02-13       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.